Labviva
United States
- Boston, Massachusetts
- 28/03/2023
- Series A
- $20,000,000
Revolutionizing life sciences procurement.
AI-powered digital marketplace for complete transparency into your supply chain
Labviva integrates with your existing purchasing software to provide you with actionable insights to make better decisions.
Keep your current suppliers, contract pricing, and your purchasing software and processes. Our digital marketplace offers unparalleled visibility into your procurement process, to empower informed decisions to drive science forward without interruptions to your research.
- Industry Biotechnology
- Website https://www.labviva.com/
- LinkedIn https://www.linkedin.com/company/labviva/
Related People
Siamak BaharlooCo Founder
United States -
Greater Boston
Labviva is a digital marketplace for life science products connecting researchers with suppliers of reagents, chemicals, and instrumentation. We create a unique relationship between scientific content and products across hundreds of brands and suppliers resulting in a seamless purchasing experience.
https://www.labviva.com/
Ciphero | $2,500,000 | (Dec 23, 2025)
beycome | $2,500,000 | (Dec 23, 2025)
Givefront | $2,000,000 | (Dec 23, 2025)
StretchSense | $2,300,000 | (Dec 23, 2025)
ZeroPhase | $6,800,000 | (Dec 23, 2025)
Peripheral Labs | $3,600,000 | (Dec 23, 2025)
Ethereal Exploration Guild | $21,000,000 | (Dec 23, 2025)
LatentForce | $1,700,000 | (Dec 23, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
Amphix Bio | $12,500,000 | (Dec 19, 2025)
Edison Scientific | $70,000,000 | (Dec 19, 2025)
Thread | $18,000,000 | (Dec 19, 2025)